Clinical trial
Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
NCT03542006 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- April 1, 2019
- Enrollment
- 35 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.